{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:29:07Z","timestamp":1780633747656,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":66,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.drugalcdep.2022.109705","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T21:11:44Z","timestamp":1668805904000},"page":"109705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-8650","authenticated-orcid":false,"given":"Natalia","family":"Konstantelos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Tourchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Lecce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-1965","authenticated-orcid":false,"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2022.109705_bib1","unstructured":"British Columbia Centre for Substance UseB.C. Ministry of Health and B.C. Ministry of Mental Health and, Addictions, 2019. Provincial guideline for the clinical management of high-risk drinking and alcohol use disorder. Vancouver."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Carmen","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2022.109705_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.35946\/arcr.v38.1.11","article-title":"Associations between socioeconomic factors and alcohol outcomes","volume":"38","author":"Collins","year":"2016","journal-title":"Alcohol Res"},{"key":"10.1016\/j.drugalcdep.2022.109705_bib4","unstructured":"Drug Shortages Canada, 2020. Drug Shortage Report for CAMPRAL [WWW Document]. Drug Shortages Canada. URL \u3008https:\/\/www.drugshortagescanada.ca\/shortage\/72306\u3009 (Accessed 2.20.21)."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib5","first-page":"219","article-title":"The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment","volume":"49","author":"Helzer","year":"1991","journal-title":"Annu. Rev. Addict. Res. Treat."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: When are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2022.109705_bib7","unstructured":"Mylan Pharmaceuticals, 2011. Product Monograph: Campral Acamprosate calcium. Etobicoke."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib8","unstructured":"Ontario Health, 2020. Problematic alcohol use and alcohol use disorder: Care for people 15 years of age and older. Toronto."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib9","unstructured":"Queen\u2019s Printer for Ontario, 2019. Limited Use Note(s): ACAMPROSATE CALCIUM 333mg DR Tab [WWW Document]. URL \u3008https:\/\/www.formulary.health.gov.on.ca\/formulary\/limitedUseNotes.xhtml?pcg9Id=289200029\u3009 (Accessed 2.16.21)."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib10","unstructured":"Queen\u2019s Printer for Ontario, 2021. Limited Use Note(s): NALTREXONE HCL 50mg Tab [WWW Document]. URL \u3008https:\/\/www.formulary.health.gov.on.ca\/formulary\/limitedUseNotes.xhtml?pcg9Id=281000003\u3009 (Accessed 2.16.21)."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1360-0443.2008.02215.x","article-title":"Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?","volume":"103","author":"Richardson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2022.109705_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-021-01235-8","article-title":"Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions","volume":"21","author":"Schaffer","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.drugalcdep.2022.109705_bib13","first-page":"e277","article-title":"First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario","volume":"63","author":"Spithoff","year":"2017","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.drugalcdep.2022.109705_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0706743720902651","article-title":"Clinical epidemiology of alcohol use disorders in military personnel versus the general population in Canada","volume":"65","author":"Taillieu","year":"2020","journal-title":"Can. J. Psychiatry"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871622004422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871622004422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:23:50Z","timestamp":1759829030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871622004422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":14,"alternative-id":["S0376871622004422"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109705","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109705"}}